The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The chocolate snacks were distributed to nine states. In December, the United States Food and Drug Administration (FDA) ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

A broccoli product sold at Walmart in Michigan was under recall. Now the FDA says the product may be considered deadly.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...